한글목차

CAR-T 요법 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 29억 8,000만 달러에서 2026년에는 34억 5,000만 달러로, CAGR 15.9%로 성장이 전망되고 있습니다. 지금까지의 성장 요인으로는 개인맞춤형 면역치료의 제한된 가용성, 초기 CAR-T 치료의 높은 비용, 병원 기반 세포 처리에 대한 의존성, 미성숙한 규제 프레임워크, CAR-T 치료에 대한 환자 인식 부족 등이 꼽힙니다.

CAR-T 요법 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 60억 8,000만 달러에 달하며, CAGR은 15.2%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 T 세포 공학의 기술 발전, 종양학 연구에 대한 투자 확대, 상업용 CAR-T 제조 시설의 확대, 규제 당국의 승인 증가, 바이오 제약 기업과 학술기관 간의 협력 강화 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 혈액 악성 종양에서 CAR-T 치료제 도입 증가, 표적 항원 특이적 CAR-T 치료제 개발, 병용요법 접근법 활용 확대, 임상시험 및 연구 프로그램 확대, 치료 비용 절감 및 접근성 향상 노력 등이 있습니다.

암 발병률 증가는 향후 CAR-T 치료제 시장의 확대를 지원할 것으로 예측됩니다. 암 이환율 증가는 시간이 지남에 따라 인구내 암 진단 건수가 증가하는 추세를 말합니다. 이러한 추세는 세포 면역 요법을 포함한 첨단 암 치료법에 대한 연구와 투자를 가속화하고 있으며, 이는 종양학 분야의 주요 발전을 상징합니다. 이러한 치료법은 암 환자의 미충족 수요를 충족시키는 데 특히 중요합니다. 예를 들어 호주 정부 기관인 호주보건복지연구원(AIHW)에 따르면 2024년 7월 기준 암 진단 건수는 2022년 16,570건에서 2023년 16만 4,694건으로 증가하여 전국적으로 상승 추세가 지속되고 있는 것으로 나타났습니다. 그 결과, 암 발병률 증가가 CAR-T 치료제 시장 확대에 기여하고 있습니다.

CAR-T 치료제 시장에서 사업을 운영하는 주요 기업은 치료의 개인화를 지원하고 환자 치료 결과를 개선하기 위해 진단 툴와 같은 기술적으로 진보된 솔루션 개발에 주력하고 있습니다. 진단 툴에는 질병 식별, 건강 상태 평가, 치료 계획 수립을 지원하는 기기, 장치, 소프트웨어가 포함됩니다. 예를 들어 2023년 2월, 미국에 본사를 둔 임상 진단 실험실인 유로핀스빌라콜(Eurofins Vilacor)은 'ExpeCT CAR T 세포의 증식 및 지속성 분석'을 발표했습니다. 이 분석법은 CAR T세포의 증식 및 지속성을 시간 경과에 따라 모니터링할 수 있으며, 치료 효과를 평가할 수 있는 실시간 데이터를 제공합니다. 또한 CAR T 세포의 불충분한 동역학으로 인해 치료 실패의 위험이 있는 환자를 식별하는 데 도움을 주어 혈액 악성 종양에서 조기 임상 개입과 치료 결과를 개선할 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Chimeric antigen receptor (CAR) T-cell therapy is a form of immunotherapy in which T-cells are taken from a patient's blood, modified in a laboratory to express a special receptor that recognizes and destroys cancer cells, and then infused back into the patient. These engineered T-cells multiply and persist in the body as living drugs, targeting cancer cells more effectively.

The primary types of chimeric antigen receptor T-cell therapy include monotherapy and combination therapy. Monotherapy involves the use of a single drug for the treatment of a disease. The target antigens include CD19, CD22, and others, and the applications cover acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma, and others.

Tariffs are impacting the CAR-T therapy market by increasing costs for imported laboratory equipment, cell culture media, and reagents required for manufacturing CAR-T cells. Segments like CD19-targeted and BCMA-targeted therapies are particularly affected, with regions such as North America and Europe facing supply chain challenges due to import duties. While tariffs create higher operational costs and potential delays, they also encourage localized production of reagents and equipment, which can strengthen domestic manufacturing capabilities and reduce long-term dependence on imports.

The car-t therapy market research report is one of a series of new reports from The Business Research Company that provides car-t therapy market statistics, including car-t therapy industry global market size, regional shares, competitors with a car-t therapy market share, detailed car-t therapy market segments, market trends and opportunities, and any further data you may need to thrive in the car-t therapy industry. This car-t therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The car-t therapy market size has grown rapidly in recent years. It will grow from $2.98 billion in 2025 to $3.45 billion in 2026 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to limited availability of personalized immunotherapy, high cost of early car-t treatments, dependence on hospital-based cell processing, nascent regulatory frameworks, low patient awareness of car-t therapy.

The car-t therapy market size is expected to see rapid growth in the next few years. It will grow to $6.08 billion in 2030 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to technological advancements in t-cell engineering, growing investment in oncology research, expansion of commercial car-t manufacturing facilities, increasing regulatory approvals, rising collaborations between biopharma and academic institutions. Major trends in the forecast period include rising adoption of car-t therapies in hematologic malignancies, development of targeted antigen-specific car-t treatments, increasing use of combination therapy approaches, expansion of clinical trials and research programs, focus on reducing therapy costs and enhancing accessibility.

The rising prevalence of cancer is anticipated to support the expansion of the CAR-T therapy market going forward. The increasing prevalence of cancer refers to the growing number of diagnosed cancer cases within a population over time. This trend has accelerated research efforts and investment in advanced cancer treatments, including cellular immunotherapies, which represent a major advancement in oncology. These therapies are particularly relevant for addressing unmet needs among cancer patients. For example, in July 2024, according to the Australian Institute of Health and Welfare, a government agency in Australia, cancer diagnoses increased from 160,570 in 2022 to 164,694 in 2023, highlighting a continued upward trend nationwide. As a result, the rising prevalence of cancer is contributing to the expansion of the CAR-T therapy market.

Leading companies operating in the CAR-T therapy market are focusing on developing technologically advanced solutions, such as diagnostic tools, to support treatment personalization and improve patient outcomes. Diagnostic tools include instruments, devices, and software used to identify diseases, assess health conditions, and guide treatment planning. For example, in February 2023, Eurofins Viracor, a US-based clinical diagnostic laboratory, launched the ExPeCT Expansion and Persistence of CAR T Assay. This assay enables longitudinal monitoring of CAR T-cell expansion and persistence, providing real-time data to assess therapy effectiveness. It also helps identify patients at risk of treatment failure due to insufficient CAR T-cell dynamics, allowing earlier clinical intervention and improved outcomes in hematological malignancies.

In July 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, acquired Iveric Bio for $5.9 billion. With this acquisition, Astellas is better positioned to support patients with ocular diseases at high risk of vision loss. The combination of Iveric Bio's ophthalmology expertise and Astellas' global resources presents an opportunity to advance treatments for blinding retinal conditions, including geographic atrophy (GA). The transaction was subject to approval by Iveric Bio's shareholders and other customary closing conditions, including regulatory approvals. Iveric Bio is a US-based biotechnology company.

Major companies operating in the car-t therapy market are Gilead Sciences, Novartis AG, Biocon, Gracell Biotechnology Ltd., CARsgen Therapeutics, Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group, PersonGen Biomedicine, Hebei Senlang Biotech, Adaptimmune (UK), Autolus Therapeutics, BioNTech, Cellectis, Celyad, Immatics, Biocad, Celgene Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Amgen, AstraZeneca, Merck, Pfizer, Juno Therapeutics, Allogene Therapeutics, Precision BioSciences, Bellicum, GlaxoSmithKline plc

North America was the largest region in the CAR-T therapy market in 2025. Western Europe was the second-largest region in the global CAR-T therapy market share. The regions covered in the car-t therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the car-t therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chimeric antigen receptor -T therapy market includes revenues earned by CAR-T therapy products and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CAR-T Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses car-t therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for car-t therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The car-t therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Monotherapy; Combination Therapy
• 2) By Target Antigen: CD19; CD22; BCMA; Other Target Antigens
• 3) By Application: Acute Lymphoblastic Leukemia; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Multiple Myeloma; Other Applications
• Subsegments:
• 1) By Monotherapy: CD19-targeted CAR-T Therapy; BCMA-Targeted CAR-T Therapy
• 2) By Combination Therapy: CAR-T Therapy With Immune Checkpoint Inhibitors; CAR-T Therapy With Other Targeted Therapies; CAR-T Therapy With Chemotherapy Or Radiotherapy
• Companies Mentioned: Gilead Sciences; Novartis AG; Biocon; Gracell Biotechnology Ltd.; CARsgen Therapeutics; Takeda Pharmaceutical Company; Astellas Pharma; Innovative Cellular Therapeutics; Cellular Biomedicine Group; PersonGen Biomedicine; Hebei Senlang Biotech; Adaptimmune (UK); Autolus Therapeutics; BioNTech; Cellectis; Celyad; Immatics; Biocad; Celgene Corporation; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Eli Lilly and Company; Amgen; AstraZeneca; Merck; Pfizer; Juno Therapeutics; Allogene Therapeutics; Precision BioSciences; Bellicum; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. CAR-T Therapy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global CAR-T Therapy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. CAR-T Therapy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global CAR-T Therapy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Car-T Therapies In Hematologic Malignancies
  • 4.2.2 Development Of Targeted Antigen-Specific Car-T Treatments
  • 4.2.3 Increasing Use Of Combination Therapy Approaches
  • 4.2.4 Expansion Of Clinical Trials And Research Programs
  • 4.2.5 Focus On Reducing Therapy Costs And Enhancing Accessibility

5. CAR-T Therapy Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Cancer Treatment Centers
• 5.3 Biopharmaceutical Companies
• 5.4 Research Institutions
• 5.5 Contract Research Organizations (Cros)

6. CAR-T Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global CAR-T Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global CAR-T Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global CAR-T Therapy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global CAR-T Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global CAR-T Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global CAR-T Therapy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. CAR-T Therapy Market Segmentation

• 9.1. Global CAR-T Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monotherapy, Combination Therapy
• 9.2. Global CAR-T Therapy Market, Segmentation By Target Antigen, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• CD19, CD22, BCMA, Other Target Antigens
• 9.3. Global CAR-T Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other Applications
• 9.4. Global CAR-T Therapy Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• CD19-targeted CAR-T Therapy, BCMA-Targeted CAR-T Therapy
• 9.5. Global CAR-T Therapy Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• CAR-T Therapy With Immune Checkpoint Inhibitors, CAR-T Therapy With Other Targeted Therapies, CAR-T Therapy With Chemotherapy Or Radiotherapy

10. CAR-T Therapy Market Regional And Country Analysis

• 10.1. Global CAR-T Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global CAR-T Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific CAR-T Therapy Market

• 11.1. Asia-Pacific CAR-T Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China CAR-T Therapy Market

• 12.1. China CAR-T Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India CAR-T Therapy Market

• 13.1. India CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan CAR-T Therapy Market

• 14.1. Japan CAR-T Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia CAR-T Therapy Market

• 15.1. Australia CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia CAR-T Therapy Market

• 16.1. Indonesia CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea CAR-T Therapy Market

• 17.1. South Korea CAR-T Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan CAR-T Therapy Market

• 18.1. Taiwan CAR-T Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia CAR-T Therapy Market

• 19.1. South East Asia CAR-T Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe CAR-T Therapy Market

• 20.1. Western Europe CAR-T Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK CAR-T Therapy Market

• 21.1. UK CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany CAR-T Therapy Market

• 22.1. Germany CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France CAR-T Therapy Market

• 23.1. France CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy CAR-T Therapy Market

• 24.1. Italy CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain CAR-T Therapy Market

• 25.1. Spain CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe CAR-T Therapy Market

• 26.1. Eastern Europe CAR-T Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia CAR-T Therapy Market

• 27.1. Russia CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America CAR-T Therapy Market

• 28.1. North America CAR-T Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA CAR-T Therapy Market

• 29.1. USA CAR-T Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada CAR-T Therapy Market

• 30.1. Canada CAR-T Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America CAR-T Therapy Market

• 31.1. South America CAR-T Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil CAR-T Therapy Market

• 32.1. Brazil CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East CAR-T Therapy Market

• 33.1. Middle East CAR-T Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa CAR-T Therapy Market

• 34.1. Africa CAR-T Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa CAR-T Therapy Market, Segmentation By Type, Segmentation By Target Antigen, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. CAR-T Therapy Market Regulatory and Investment Landscape

36. CAR-T Therapy Market Competitive Landscape And Company Profiles

• 36.1. CAR-T Therapy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. CAR-T Therapy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. CAR-T Therapy Market Company Profiles
  • 36.3.1. Gilead Sciences Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Biocon Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Gracell Biotechnology Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. CARsgen Therapeutics Overview, Products and Services, Strategy and Financial Analysis

37. CAR-T Therapy Market Other Major And Innovative Companies

• Takeda Pharmaceutical Company, Astellas Pharma, Innovative Cellular Therapeutics, Cellular Biomedicine Group, PersonGen Biomedicine, Hebei Senlang Biotech, Adaptimmune (UK), Autolus Therapeutics, BioNTech, Cellectis, Celyad, Immatics, Biocad, Celgene Corporation, Johnson & Johnson

38. Global CAR-T Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The CAR-T Therapy Market

40. CAR-T Therapy Market High Potential Countries, Segments and Strategies

• 40.1 CAR-T Therapy Market In 2030 - Countries Offering Most New Opportunities
• 40.2 CAR-T Therapy Market In 2030 - Segments Offering Most New Opportunities
• 40.3 CAR-T Therapy Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer